Hepatic Cell News Volume 6.44 | Dec 2 2022

    0
    18








    2022-11-02 | HCN 6.43


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.43 – 2 December, 2022
    TOP STORY

    IL6 Supports Long-Term Expansion of Hepatocytes In Vitro

    Investigators discovered IL6, combined with epidermal growth facto and hepatocyte growth factor, promoted long-term expansion of primary mouse hepatocytes in vitro in simple 2D culture, by converting hepatocytes into induced hepatic progenitor cells.
    [Nature Communications]

    Full Article
    ON1153CC-CPA-Liver Organoid_160 x 600_728 x 90
    PUBLICATIONSRanked by the impact factor of the journal

    GL-V9 Alleviates Liver Fibrosis via Triggering GATA4-Mediated Senescence in Activated Hepatic Stellate Cells

    Bile duct ligation and carbon tetrachloride challenge were used to assess anti-fibrotic effects of GL-V9 in vivo. Mouse primary hepatic stellate cells and human HSC line LX2 also served as an in vitro liver fibrosis model.
    [British Journal of Pharmacology]

    Abstract

    Inhibition of 11β-Hydroxysteroid Dehydrogenase 1 Relieves Fibrosis through Depolarizing of Hepatic Stellate Cell in NASH

    Investigators found that pharmacological and genetic inhibition of 111β-hydroxysteroid dehydrogenase type 1 resulted in reprogramming of hepatic stellate cell activation via inhibition of p-SMAD3, α-SMA, Snail, and Col1A1 in a fibrotic environment and in multicellular hepatic spheroids.
    [Cell Death & Disease]

    Full Article

    A20 Interacts with mTORC2 to Inhibit the mTORC2/Akt/Rac1 Signaling Axis in Hepatocellular Carcinoma Cells

    Scientists analyzed the relationship between A20 and Rac1 activation, as well as the activity of Akt and mTORC2, two signaling components upstream of Rac1, using gain and loss of function experiments.
    [Cancer Gene Therapy]

    Abstract

    Proteomic Overview of Hepatocellular Carcinoma Cell Lines and Generation of the Spectral Library

    The authors presented the proteome of nine commonly used HCC cell lines covering 9,208 protein groups, and the HCC spectral library containing 253,921 precursors, 168,811 peptides and 10,098 protein groups.
    [Scientific Data]

    Full Article

    In Silico and In Vitro Analysis of microRNAs with Therapeutic Potential in Atherosclerosis

    The inhibitory effects of the identified miRNAs in HepG2 and Huh7 cells were verified by real-time PCR. The MTT assay was utilized to evaluate cell cytotoxicity effects of miRNAs.
    [Scientific Reports]

    Full Article

    Dialysis Based-Culture Medium Conditioning Improved the Generation of Human Induced Pluripotent Stem Cell Derived-Liver Organoid in a High Cell Density

    Investigators developed a simple dialysis-based medium conditioning that fully utilized growth factors accumulation to improve hepatic differentiation of human induced pluripotent stem cells at a high cell density.
    [Scientific Reports]

    Full Article

    Dopamine Receptor D3 Is Related to Prognosis in Human Hepatocellular Carcinoma and Inhibits Tumor Growth

    Cell growth was tested by CCK8 assay, and Transwell assays were performed to assess cancer cell migration and invasion. The cAMP/ERK/CREB signaling pathway was evaluated by Western blot analysis and ELISA.
    [BMC Cancer]

    Full Article

    The Expression Characteristics and Clinical Significance of ACP6, a Potential Target of Nitidine Chloride, in Hepatocellular Carcinoma

    Researchers appraised the clinico-pathological significance of acid phosphatase type 6 in HCC via organizing expression profiles from globally multi-center microarrays and RNA-seq datasets. The molecular basis of ACP6 in HCC was explored through multidimensional analysis.
    [BMC Cancer]

    Full Article
    Scientific resources to support your stem cell research. Learn More!
    REVIEWS

    Reprograming Immune Microenvironment Modulates CD47 Cancer Stem Cells in Hepatocellular Carcinoma

    One of the most common causes of cancer chemoresistance and relapse is the presence and percentage of cancer stem cells (CSCs), among them CD47+ CSCs.
    [International Immunopharmacology]

    Abstract

    SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes

    Investigators provide an updated summary on the current pathogenesis and mechanism of liver injury in the setting of SARS-CoV-2 infection, the association between health outcomes and SARS-CoV-2 infection in patients with chronic liver disease.
    [Gut and Liver]

    Full Article
    INDUSTRY AND POLICY NEWS

    Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to the UK Medicines and Healthcare Products Regulatory Agency

    Shanghai Junshi Biosciences Co., Ltd announced that the company has submitted a marketing authorization application to the United Kingdom’s Medicines and Healthcare products Regulatory Agency for toripalimab
    [Shanghai Junshi Biosciences Co., Ltd (GlobeNewswire, Inc.)]

    Press Release
    FEATURED EVENT

    Stem Cells: Advances in the Application of Stem Cells and Their Role In Vivo

    February 5 – 8, 2023
    Keystone, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Immunology of Liver Disease Job

    The Ottawa Hospital – Ottawa, Ontario, Canada

    Postdoctoral Fellow – Cancer Tumor Microenvironment

    Centre for Oncology and Immunology – Hong Kong, Hong Kong

    Investigators – Liver Diseases

    Cleveland Clinic, Lerner Research Institute – Cleveland, Ohio, United States

    Postdoctoral Fellow – Intestinal Biology and Colorectal Cancer

    Norwegian University of Science and Technology – Trondheim, Norway

    Postdoctoral Position – Molecular Epidemiology

    International Agency for Research on Cancer, WHO – Lyon, France

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter